-Reuters
Oramed Pharmaceuticals Q3 EPS $(0.18) Down From $(0.17) YoY
Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly losses of $(0.18) per share. This is a 5.88 percent decrease over losses of $(0.17) per share from the same period last year.